Mogamulizumab (Anti-CCR4 / CD194)
A2568
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameMogamulizumab (Anti-CCR4 / CD194)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionMogamulizumab (Anti-CCR4 / CD194) is a defucosylated humanized recombinant monoclonal antibody targeting CCR4. Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL). MW:145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203